Grant: CIHR Fellowship
Direct Payment
$95,833.00
Role of autophagy in normal and leukemic hematopoietic stem cells
FY 2011-12
Summary
In humans, and in mice, the blood system is maintained by a rare group of cells, called blood-forming hematopoietic stem cells (HSCs), found in the marrow cavity of the bones. HSCs are the only blood cells that can continuously produce mature cells, such as red blood cells, platelets, and immune cells. To permit this feat, HSCs have the unique ability to replicate themselves at the identical, a process called self-renewal, and to produce daughter cells that differentiate into all types of mature blood cells. Throughout life, these stem cells are exposed to a variety of stresses, such as decreased nutrient availability or damage to cellular components, which can threaten their function and survival. HSCs have developed regulatory processes to ensure their continued health and existence during these periods of stress. Using mouse blood as a model system, we have recently found that HSCs are protected from the killing effect of cellular stresses by an important process of cellular maintenance, called autophagy. Autophagy is a "trash collection" mechanism, which removes damaged cellular components that can threaten the cell's well-being if left to accumulate. By re-processing cellular components and generating energy, autophagy can allow cells to survive periods of cellular stress. Blood cancers also rely on a population of stem cells, termed leukemic-stem cells, to sustain and perpetuate disease. Furthermore, the disruption of autophagy has been shown to promote the development of cancers. Here, we propose to test how failure in regulating autophagy contributes to the development of cancers in the blood system. We intend to identify the defects that contribute to autophagy deregulation in HSCs isolated from mice with blood cancers, and to develop new treatments for blood cancers.
Department
Program
CIHR Fellowship
Recipient
Location
California, United States of America
Type
Grant
Source
CIHR Funding Decisions Database
As published
Id
242611
Name
Warr Matthew R
Region
California
Country
United States of America
Orgtype
Research Institution
Instname2
Cancer Research
Theme2
Biomedical
Prcname2
Fellowships - Post-PhD
Projecttitle
Role of autophagy in normal and leukemic hematopoietic stem cells
Programtype2
Fellowship Programs
Orgnameinp2
Direct Payment
Cihramount2
$95,833
Cihrequipment2
$0
Programname2
CIHR Fellowship
Keyworddelim
Apoptosis; Autophagy; Bcrabl; Cancer Stem Cell; Chronic Myelogenous Leukemia; Hematopoiesis; Hematopoietic Stem Cell; Junb; Leukemia; Myeloid Progenitor
Abstract
In humans, and in mice, the blood system is maintained by a rare group of cells, called blood-forming hematopoietic stem cells (HSCs), found in the marrow cavity of the bones. HSCs are the only blood cells that can continuously produce mature cells, such as red blood cells, platelets, and immune cells. To permit this feat, HSCs have the unique ability to replicate themselves at the identical, a process called self-renewal, and to produce daughter cells that differentiate into all types of mature blood cells. Throughout life, these stem cells are exposed to a variety of stresses, such as decreased nutrient availability or damage to cellular components, which can threaten their function and survival. HSCs have developed regulatory processes to ensure their continued health and existence during these periods of stress. Using mouse blood as a model system, we have recently found that HSCs are protected from the killing effect of cellular stresses by an important process of cellular maintenance, called autophagy. Autophagy is a "trash collection" mechanism, which removes damaged cellular components that can threaten the cell's well-being if left to accumulate. By re-processing cellular components and generating energy, autophagy can allow cells to survive periods of cellular stress. Blood cancers also rely on a population of stem cells, termed leukemic-stem cells, to sustain and perpetuate disease. Furthermore, the disruption of autophagy has been shown to promote the development of cancers. Here, we propose to test how failure in regulating autophagy contributes to the development of cancers in the blood system. We intend to identify the defects that contribute to autophagy deregulation in HSCs isolated from mice with blood cancers, and to develop new treatments for blood cancers.
Competitiondate
201110
Approvedterm2
1 yr 11 mths
Pinamesdelim
Warr, Matthew R
Approvedterm
1 an 11 mois
Cihrcontribution2
~ $95,833~ $0~